Parkman Healthcare Partners’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-179,899
Closed -$2.09M 96
2024
Q1
$2.09M Sell
179,899
-39,549
-18% -$460K 0.26% 85
2023
Q4
$2.45M Sell
219,448
-144,105
-40% -$1.61M 0.35% 69
2023
Q3
$5.61M Buy
363,553
+14,678
+4% +$227K 1.03% 32
2023
Q2
$6.61M Buy
348,875
+101,919
+41% +$1.93M 1.15% 27
2023
Q1
$3.76M Sell
246,956
-85,924
-26% -$1.31M 0.82% 43
2022
Q4
$4.24M Buy
332,880
+107,880
+48% +$1.37M 1.13% 36
2022
Q3
$1.3M Buy
+225,000
New +$1.3M 0.37% 68
2022
Q1
Sell
-152,098
Closed -$1.99M 83
2021
Q4
$1.99M Buy
152,098
+6,250
+4% +$81.7K 0.44% 57
2021
Q3
$2.86M Buy
145,848
+10,000
+7% +$196K 0.72% 42
2021
Q2
$2.54M Buy
135,848
+33,685
+33% +$630K 0.56% 50
2021
Q1
$2.42M Buy
102,163
+5,490
+6% +$130K 0.56% 48
2020
Q4
$2.36M Sell
96,673
-13,327
-12% -$325K 0.6% 55
2020
Q3
$2.82M Buy
+110,000
New +$2.82M 0.75% 48